Hisamitsu Pharmaceutical Co., Inc. manufactures and sells pharmaceuticals in Japan. The company offers OTC products, such as, external pain-relieving drugs under the SALONPAS, NOBINOBI, SALONSIP, AIR, SALONPAS, and FEITAS; BUTENALOCK, a remedy for athlete′s foot; and ALLEGRA FX, a sinus medication for allergies. It also manufactures and sells quasi-drugs and cosmetics; MOHRUS TAPE and MOHRUS PAP XR, a transdermal analgesic anti-inflammatory drug; and patches for female hormone, asthma, and overactive bladders. It also exports its products to Asia, the United States, and the European area. Hisamitsu Pharmaceutical Co., Inc. was founded in 1847 and is headquartered in Tosu, Japan.

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Nakatomi, Kazuhide

Employees

2,799

Website

www.global.hisamitsu

IPO Date

2001-01-01

Headquarters

Tashirodaikan-machi 408, Tosu, Saga, 841-0017, Japan

Socials

NEWSLETTER

View Data Providers

NEWSLETTER

View Data Providers

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

Hisamitsu Pharmaceutical 4530

Hisamitsu Pharmaceutical Earnings Call Summary

Hisamitsu Pharmaceutical Earnings

Transcripts

Events

About Hisamitsu Pharmaceutical Co., Inc.

Hisamitsu Pharmaceutical
4530